Anticancer activity of carbon dots with different chemical compositions against Lewis lung carcinoma in mice
Abstract
This study investigated the antitumor potential of carbon dots (CDs) with distinct surface chemistries in a Lewis lung carcinoma (LLC) mouse model. The effects of CD_3011, CDN19, and CDF19 were evaluated in terms of tumor growth, systemic biochemical and hematological responses, and histopathological changes. All tested formulations produced measurable tumor growth inhibition, with statistically significant effects emerging between days 12 and 14 of treatment. Relative tumor volume analysis demonstrated significant inhibition for CDN19 and CDF19, whereas CD_3011 showed a non-significant trend, likely due to higher variability. Tumor growth inhibition indices confirmed CDN19 as the most potent formulation, also showing significant suppression of metastasis. Vehicle-treated tumor-bearing mice exhibited elevated AST, GGT, and LDH levels, decreased ALP and urea, leukocyte redistribution (reduced lymphocytes, increased granulocytes), and reduced erythrocyte counts. CD treatment partially normalized these tumor-associated systemic alterations, with most parameters remaining within physiological ranges. Histologically, Vehicle-treated animals displayed renal stress, hepatic micrometastases, inflammatory infiltration, and high tumor proliferation with limited apoptosis. CD administration attenuated liver metastasis, reduced inflammatory and vascular changes, suppressed tumor proliferation, and enhanced apoptosis and necrosis, particularly in the CDN19 group. Mild renal alterations were noted in some CD-treated groups, consistent with prior toxicity observations. Overall, the findings demonstrate that surface-modified carbon dots-especially CDN19-exert antitumor, anti-metastatic, and systemic protective effects, supporting their potential as multifunctional nanotherapeutic agents in cancer treatment.
Related
- Viroelixir Exhibits Cell-Line-Specific Anticancer Activity and Enhances Chemosensitivity in Oral Squamous Cell Carcinoma: Associated Changes in Apoptosis, Redox Homeostasis, and Oncogenic Signaling
- Multichromatic Dynamic Control of Multi-Membered Microbial Consortia Compositions for Chemical Production
- Different dietary compositions shape reproductive physiology in Litopenaeus vannamei broodstock
- Partial purification, experimental characterization of L-arginase from Alcaligenes aquatilis BC2 and determination of in vitro anticancer activity
- The Effects of Different Feed Substrates on Production Performance, Digestibility, and Chemical Composition of Zophobas morio Larvae
BibTeX
@article{kuznietsova2026anticancer,
title = {{Anticancer activity of carbon dots with different chemical compositions against Lewis lung carcinoma in mice}},
author = {Halyna Kuznietsova and Nataliia Dziubenko and Alexander Zaderko and Vladimir Lysenko and Valeriy Skryshevsky},
journal = {Discover Oncology},
year = {2026},
month = oct,
doi = {10.1007/s12672-026-05980-4},
url = {https://hal.science/hal-05781113v1},
note = {CC BY-NC-ND 4.0},
}
RIS
TY - JOUR
TI - Anticancer activity of carbon dots with different chemical compositions against Lewis lung carcinoma in mice
AU - Halyna Kuznietsova
AU - Nataliia Dziubenko
AU - Alexander Zaderko
AU - Vladimir Lysenko
AU - Valeriy Skryshevsky
PY - 2026
DA - 2026/10/06
JO - Discover Oncology
DO - 10.1007/s12672-026-05980-4
UR - https://hal.science/hal-05781113v1
AB - This study investigated the antitumor potential of carbon dots (CDs) with distinct surface chemistries in a Lewis lung carcinoma (LLC) mouse model. The effects of CD_3011, CDN19, and CDF19 were evaluated in terms of tumor growth, systemic biochemical and hematological responses, and histopathological changes. All tested formulations produced measurable tumor growth inhibition, with statistically significant effects emerging between days 12 and 14 of treatment. Relative tumor volume analysis demonstrated significant inhibition for CDN19 and CDF19, whereas CD_3011 showed a non-significant trend, likely due to higher variability. Tumor growth inhibition indices confirmed CDN19 as the most potent formulation, also showing significant suppression of metastasis. Vehicle-treated tumor-bearing mice exhibited elevated AST, GGT, and LDH levels, decreased ALP and urea, leukocyte redistribution (reduced lymphocytes, increased granulocytes), and reduced erythrocyte counts. CD treatment partially normalized these tumor-associated systemic alterations, with most parameters remaining within physiological ranges. Histologically, Vehicle-treated animals displayed renal stress, hepatic micrometastases, inflammatory infiltration, and high tumor proliferation with limited apoptosis. CD administration attenuated liver metastasis, reduced inflammatory and vascular changes, suppressed tumor proliferation, and enhanced apoptosis and necrosis, particularly in the CDN19 group. Mild renal alterations were noted in some CD-treated groups, consistent with prior toxicity observations. Overall, the findings demonstrate that surface-modified carbon dots-especially CDN19-exert antitumor, anti-metastatic, and systemic protective effects, supporting their potential as multifunctional nanotherapeutic agents in cancer treatment.
SN - 2730-6011
ER -